In a letter to U.S. trade representatives, the AHA challenged the Biden administration’s proposal to increase tariff rates on syringes, needles, personal protective equipment, and medical and surgical gloves. The administration said the plan will confront China’s unfair trade practices and incentivize domestic medical supply manufacturing.
The AHA disagrees, arguing “this strategy may fail or bring negative unintended consequences.”
China-based manufacturers dominate the market for some commonly used medical supplies, and other sources are unlikely to meet domestic demand, the AHA said, so the U.S. healthcare industry might have to continue buying these more expensive products. The organization also said hospitals have existing contracts with China-based manufacturers, and it is burdensome to test and adopt new devices.
Read the letter here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
